NCT04546074 2023-10-03Imatinib Mesylate in Combination With Pembrolizumab in Patients With MelanomaKeio UniversityPhase 1/2 Unknown22 enrolled
NCT01782508 2013-02-04A Phase II Study of Imatinib Versus Interferon as Adjuvant Therapy in KIT-mutated MelanomaPeking University Cancer Hospital & InstitutePhase 2 Unknown40 enrolled